British journal of cancer
Cure8 research brief
Why This Matters
The study identifies a specific fibroblast–macrophage interaction driven by collagen IV that may explain how chronic IBD inflammation progresses to fibrosis and cancer, highlighting possible new molecular targets to reduce cancer risk.
Who Should Pay Attention
Researchers studying IBD, fibrosis, and tumor microenvironment; translational clinicians interested in biomarkers and novel therapeutic targets for IBD-associated cancer.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The research is a laboratory and transcriptomic investigation (single-nuclei and spatial RNA techniques) supported by in vitro co-culture and animal experiments.
The authors report that CXCL14+ fibroblasts increase COL4A1/A2 (collagen IV) via SOX4 activation, which engages ITGB1/CD44 on SPP1+ macrophages and promotes their pro-tumorigenic differentiation; reciprocal signaling by SPP1+ macrophages (via TGF-β1) further stimulates fibroblast collagen IV production, creating a feed-forward loop.
The paper suggests inhibiting collagen IV secretion reduced fibrosis and blocked the inflammation–cancer transition in their models. Key takeaways for patients and clinicians: this is mechanistic, preclinical research that maps specific cell types and molecular interactions that may underlie IBD-associated fibrosis and cancer risk.
It points to collagen IV and the CXCL14–SPP1 cellular axis as potential targets for future therapies, but the findings come from lab models and need validation in human clinical studies before changing care.
Keep In Mind
This is mechanistic, preclinical research using single-nuclei and spatial transcriptomics plus lab models. Results suggest potential targets but require validation in human clinical studies before clinical application.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationBritish journal of cancer
AuthorsHaonan Zhang, Yulu Shi, Qiuyu Song +14 more
InstitutionDepartment of Gastroenterology; Guangdong Provincial Key Laboratory of Major Obstetric Diseases; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedOct 17, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: Competing interests: The authors declare no competing interests. Ethics approval and consent to participate: Collection and usage of clinical and pathological specimens were approved by the Third Affiliated Hospital of Guangzhou Medical University’s Ethical Committee Board (Approval number: EN-2024300). All patients provided informed consent for sample collection and use. The use of animals and all procedures were approved by the Animal Experimentation Ethics Committee of Guangzhou Medical University (S2024-009).
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
NOX1 Drives Inflammatory Bowel Disease Through Oxidant-Dependent Stabilization of IκBζ.
Identifies a redox-sensitive NOX1–ROS–IκBζ pathway that may sustain intestinal inflammation in IBD and points to a new molecular target for future therapies.
Stromal ARHGEF15 Correlates With Inflammatory EMT and Stromal-Immune Crosstalk During Inflammatory Bowel Disease-To-Colorectal Cancer Progression.
People with IBD are at higher risk for colorectal cancer; identifying stromal genes that track inflammation-driven EMT could help researchers find biomarkers or targets that explain how chronic inflammation promotes...
Disease- and Region-Specific Molecular Patterns Involving miRNAs and Associated Signalling Pathways and Epithelial Cell-Fate Responses in PSC-Associated Ulcerative Colitis
The work highlights molecular differences between PSC-UC and typical UC that could help explain higher colorectal cancer risk in PSC-UC and suggests candidate miRNA biomarkers (eg, miR-155) for further study.